logo

Ultragenyx Pharmaceutical Inc (RARE)



Trade RARE now with
  Date
  Headline
5/7/2018 4:08:03 PM Ultragenyx Pharmaceutical Q1 EPS $0.62 Vs. Loss $1.63 Year Ago
4/30/2018 8:34:59 AM Ultragenyx And Kyowa Kirin Announce Crysvita Launched In U.S. For The Treatment Of XLH In Children And Adults
4/23/2018 8:35:42 AM Ultragenyx Announces Filing And FDA Clearance Of IND Application For DTX401
3/7/2018 8:03:17 AM Ultragenyx Unveils Positive Topline Results, DMC Review From First Cohort Of Phase 1/2 Clinical Study Of DTX301
2/21/2018 7:27:04 AM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) FY18 Estimate To -4.15 From -4.06
2/21/2018 7:26:47 AM Wedbush Is Increasing Ultragenyx Pharmaceutical Inc (RARE) Q3 18 Estimate To -0.68 From -0.71
2/21/2018 7:26:32 AM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) Q2 18 Estimate To -2.03 From -2.04
2/21/2018 7:26:19 AM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) Q1 18 Estimate To 0.63 From 0.74
2/20/2018 4:06:19 PM Ultragenyx Pharma Q4 Loss Per Share $1.89 Vs Loss $1.75 Last Year
1/29/2018 8:31:36 AM Ultragenyx Appoints Camille Bedrosian As Chief Medical Officer And EVP
1/23/2018 9:41:46 PM Ultragenyx Pharma Prices Public Offering Of 4.39 Mln Shares At $57.00/shr
1/22/2018 4:15:55 PM Ultragenyx Announces Proposed Public Offering Of Common Stock
1/17/2018 4:35:27 PM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) FY18 Rev. Estimate To 235.8 M From 226.6 M
1/17/2018 4:35:08 PM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) Q4 18 Rev. Estimate To 14.2 M From 14.0 M